MCL1 and acute myeloid leukemia: These include biochemical assays such as surface plasmon resonance (SPR) and enzyme inhibition kinetics to confirm direct binding of compound 8l to Mcl-1, as well as MTT and apoptosis assays using AML cell lines (MV4-11, HL-60) to confirm antiproliferative effects.